000 | 01904 a2200529 4500 | ||
---|---|---|---|
005 | 20250516155701.0 | ||
264 | 0 | _c20140213 | |
008 | 201402s 0 0 eng d | ||
022 | _a1546-1696 | ||
024 | 7 |
_a10.1038/nbt.2620 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTaipale, Mikko | |
245 | 0 | 0 |
_aChaperones as thermodynamic sensors of drug-target interactions reveal kinase inhibitor specificities in living cells. _h[electronic resource] |
260 |
_bNature biotechnology _cJul 2013 |
||
300 |
_a630-7 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCell Cycle Proteins _xgenetics |
650 | 0 | 4 | _aCrizotinib |
650 | 0 | 4 | _aDrug Approval |
650 | 0 | 4 | _aDrug Interactions |
650 | 0 | 4 |
_aHSP90 Heat-Shock Proteins _xmetabolism |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aMolecular Chaperones _xmetabolism |
650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
650 | 0 | 4 |
_aPhosphotransferases _xantagonists & inhibitors |
650 | 0 | 4 | _aProtein Binding |
650 | 0 | 4 |
_aProtein Kinase Inhibitors _xtherapeutic use |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-ets _xmetabolism |
650 | 0 | 4 |
_aPyrazoles _xtherapeutic use |
650 | 0 | 4 |
_aPyridines _xtherapeutic use |
650 | 0 | 4 |
_aReceptor, trkC _xmetabolism |
650 | 0 | 4 |
_aRepressor Proteins _xmetabolism |
650 | 0 | 4 | _aSubstrate Specificity |
650 | 0 | 4 | _aXenograft Model Antitumor Assays |
650 | 0 | 4 | _aETS Translocation Variant 6 Protein |
700 | 1 | _aKrykbaeva, Irina | |
700 | 1 | _aWhitesell, Luke | |
700 | 1 | _aSantagata, Sandro | |
700 | 1 | _aZhang, Jianming | |
700 | 1 | _aLiu, Qingsong | |
700 | 1 | _aGray, Nathanael S | |
700 | 1 | _aLindquist, Susan | |
773 | 0 |
_tNature biotechnology _gvol. 31 _gno. 7 _gp. 630-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/nbt.2620 _zAvailable from publisher's website |
999 |
_c22877144 _d22877144 |